Cell and Gene Manufacturing and Logistics

  1. DynaDrive S.U.B. Video Series 4/1/2026

    Explore DynaDrive Single-Use Bioreactors through expert videos covering reactor design, mixing performance, sparge technology, and scalable workflows from bench-scale to commercial production.

  2. Scaling MSC Therapies: Overcoming MSC Manufacturing Risks And Barriers 4/1/2026

    Explore strategies for scaling MSC manufacturing while mitigating biological and operational risks. Learn how closed-system platforms and optimized workflows accelerate the path to commercial cell therapy.

  3. From QM To QMM For AI-Assisted Pharmaceutical Manufacturing Operations 4/1/2026

    The FDA’s focus has shifted from tracking quality metrics to promoting quality management maturity. AI/ML is poised to help with efforts, though it introduces additional complexity around data integrity.

  4. Scale‑Up Challenges In Adenovirus GMP Manufacturing 3/31/2026

    Structured process development enables scalable GMP adenovirus manufacturing with optimized performance, yield, and control at large scale.

  5. The Systems And Choreography Needed For Grade B ATMP Material Transfer 3/31/2026

    Traditional material air locks often fail to account for the sheer throughput needed for cell therapy workflows. These design tips help prevent traffic jams.

  6. Automated Cryo‑Processed Leukapheresis For CAR‑T Manufacturing 3/30/2026

    Automated, closed cryo‑processing of leukapheresis preserves cell quality and functionality, enabling flexible, reproducible starting material for both autologous and allogeneic CAR‑T manufacturing.

  7. Building Stability Through Integrated Cryopreservation 3/30/2026

    Early integration of standardized, GMP-aligned cryopreservation improves consistency, documentation, and scalability in advanced therapy programs as they progress toward regulatory submissions.

  8. DynaDrive Single-Use Bioreactors Drilled-Hole Sparge Technology 3/30/2026

    Uniform bubble size and consistent mass transfer across scales through drilled-hole sparge technology improves oxygen delivery and CO2 stripping in demanding cell culture processes.

  9. DynaDrive Single-Use Bioreactors - One Reactor, Many Volumes 3/30/2026

    Single-use bioreactors with turndown ratios up to 20:1 enable facilities to operate across wide volume ranges within the same vessel, streamlining seed trains and reducing capital requirements for multi-product operations.

  10. Scale With Confidence From Bench To Commercial Production 3/30/2026

    Consistent vessel design, sparging, and bag materials across 1L to 5,000L volumes enable predictable bioreactor scale-up from development through commercial manufacturing.